Cognitive Function News and Research RSS Feed - Cognitive Function News and Research

Cognition is a concept used in different ways by different disciplines, but is generally accepted to mean the process of thought. For example, in psychology and cognitive science it refers to an information processing view of an individual's psychological functions.
Scientists reveal mechanisms that create 'Mexican waves' in brain

Scientists reveal mechanisms that create 'Mexican waves' in brain

Scientists have revealed the mechanisms that enable certain brain cells to persuade others to create 'Mexican waves' linked with cognitive function. [More]
Study reveals association between high burden of AFib and lower cognitive function

Study reveals association between high burden of AFib and lower cognitive function

iRhythm Technologies, Inc. announced today that study results presented during the American Heart Association Scientific Sessions showed an association between a high burden of atrial fibrillation (AFib) and lower cognitive function, specifically executive and verbal function. [More]
Smart drug Modafinil can impair cognitive performance in healthy students

Smart drug Modafinil can impair cognitive performance in healthy students

It is claimed one in five students have taken the 'smart' drug Modafinil to boost their ability to study and improve their chances of exam success. [More]
Pathological guilt in preschool years linked to brain changes, increases risk for recurrent depression

Pathological guilt in preschool years linked to brain changes, increases risk for recurrent depression

In school-age children previously diagnosed with depression as preschoolers, a key brain region involved in emotion is smaller than in their peers who were not depressed, scientists have shown. [More]
FDA accepts Amgen's evolocumab BLA for review

FDA accepts Amgen's evolocumab BLA for review

Amgen today announced that the U.S. Food and Drug Administration has accepted for review Amgen's Biologics License Application (BLA) for evolocumab for the treatment of high cholesterol. [More]
Neuronetrix selected to support upcoming ANAVEX 2-73 Phase 2a clinical trial

Neuronetrix selected to support upcoming ANAVEX 2-73 Phase 2a clinical trial

Neuronetrix has been selected by Anavex Life Sciences Corp. to support the upcoming Phase 2a clinical trial for ANAVEX 2-73, a symptomatic and potentially disease-modifying treatment for Alzheimer's disease. Neuronetrix will be utilizing their COGNISION System to measure and analyze cognitive biomarkers in study participants. [More]
Accumulated environmental risks have substantial impact on schizophrenia

Accumulated environmental risks have substantial impact on schizophrenia

Accumulation of environmental risk factors has a “huge” effect on age at schizophrenia onset, German researchers report. [More]
High risk for congenital heart defects in Down syndrome provides tool to identify changes in genes

High risk for congenital heart defects in Down syndrome provides tool to identify changes in genes

Down syndrome is the most common chromosomal abnormality in humans, involving a third copy of all or part of chromosome 21. In addition to intellectual disability, individuals with Down syndrome have a high risk of congenital heart defects. However, not all people with Down syndrome have them – about half have structurally normal hearts. [More]
Cannabis use during adolescence: an interview with Dr Edmund Silins

Cannabis use during adolescence: an interview with Dr Edmund Silins

We know quite a lot about the effects of cannabis on the body and brain but there is still a need to better understand its impact on the health, well-being and development of long term users. [More]
NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial

NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Veterans Affairs for a clinical trial to evaluate the benefits of non-invasive, external Trigeminal Nerve Stimulation (eTNS) for patients with traumatic brain injury (TBI) in a Phase I clinical trial. [More]
New findings link obesity and dietary factors to late-life dementias

New findings link obesity and dietary factors to late-life dementias

Difficulties learning, remembering, and concentrating. An inability to resist environmental temptations to eat. A lifetime of progressive deterioration in the brain. [More]
Study shows rats, mice perform similarly in cognitive tests; offers implications for cognition research

Study shows rats, mice perform similarly in cognitive tests; offers implications for cognition research

It's one of those ideas that seems to make perfect sense: the bigger the brain, the more intelligent the creature. [More]
Researchers launch landmark new program to explore potential impact of medical marijuana

Researchers launch landmark new program to explore potential impact of medical marijuana

Thanks to a $500,000 gift from international best-selling author and mental health advocate Patricia Cornwell, McLean Hospital and Harvard Medical School researchers will launch a landmark new program that will more fully explore the potential impact of medical marijuana on cognition, brain structure and function. [More]
Standard cognition test falls short in Parkinson’s disease patients

Standard cognition test falls short in Parkinson’s disease patients

There is a wide range of cognitive function, including dementia, among patients with Parkinson’s disease who are classed as cognitively normal on the Mini-Mental State Examination, research shows. [More]
Research findings provide more details about earliest stages of neurodegenerative disease

Research findings provide more details about earliest stages of neurodegenerative disease

The link between a protein typically associated with Alzheimer's disease and its impact on memory and cognition may not be as clear as once thought, according to a new study from the University of Wisconsin-Madison's Waisman Center. [More]
New study sheds light on relationship between schizophrenia and smoking stems

New study sheds light on relationship between schizophrenia and smoking stems

Schizophrenia is associated with increased rates and intensity of tobacco smoking. A growing body of research suggests that the relationship between schizophrenia and smoking stems, in part, from an effort by patients to use nicotine to self-medicate symptoms and cognitive impairment associated with the disease. [More]
Research findings could help explain how some people stave off dementia

Research findings could help explain how some people stave off dementia

The human brain is capable of a neural workaround that compensates for the buildup of beta-amyloid, a destructive protein associated with Alzheimer's disease, according to a new study led by researchers at the University of California, Berkeley. [More]
New research illustrates how fear arises in the brain

New research illustrates how fear arises in the brain

An estimated 8% of Americans will suffer from post traumatic stress disorder (PTSD) at some point during their lifetime. Brought on by an overwhelming or stressful event or events, PTSD is the result of altered chemistry and physiology of the brain. [More]
Adequate levels of vitamin E critical for young, elderly and pregnant women

Adequate levels of vitamin E critical for young, elderly and pregnant women

Amid conflicting reports about the need for vitamin E and how much is enough, a new analysis published today suggests that adequate levels of this essential micronutrient are especially critical for the very young, the elderly, and women who are or may become pregnant. [More]
Discovery reveals promising target for treatment of end-stage heart failure

Discovery reveals promising target for treatment of end-stage heart failure

As a heart fails, losing its ability to squeeze blood through the circulatory system, the body releases a neurohormone that interferes with the heart's best chance to improve contractility, a team of Temple University School of Medicine researchers show in a study published September 9th in the American Heart Association journal, Circulation. [More]